Aurora Cannabis (ACB) Capital Expenditures (2017 - 2025)

Aurora Cannabis (ACB) has reported Capital Expenditures for 9 consecutive years, with $20.6 million the latest figure, recorded in Q1 2025.

• Quarterly Capital Expenditures fell 1.04% year-over-year to $20.6 million in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $10.1 million (up 44.7% YoY) and the FY2026 annual result came in at $16.3 million, up 50.65% from the prior year.
• Capital Expenditures grew to $20.6 million in Q1 2025 per ACB's latest filing, from -$3.5 million in the prior quarter.
• Over the last five years, Capital Expenditures for ACB reached as high as $77.2 million in Q2 2021 and fell as low as -$9.6 million in Q1 2021.
• A 5-year average of $3.6 million and a median of -$3.8 million in 2024 frame the typical range for Capital Expenditures.
• Annual changes were most pronounced in 2021 — Capital Expenditures surged 415.35% — and 2022, when it slumped 105.99%.
• Year by year, Capital Expenditures stood at -$8.9 million in 2021, then advanced by 2.21% to -$8.7 million in 2022, then jumped by 76.66% to -$2.0 million in 2023, then sank by 70.55% to -$3.5 million in 2024, then soared by 693.35% to $20.6 million in 2025.
• According to Business Quant data, Capital Expenditures over the past three periods registered $20.6 million, -$3.5 million, and -$3.3 million for Q1 2025, Q4 2024, and Q3 2024 respectively.